Credit: Sergey Nivens/Shutterstock.com
The median annual price of 13 new drugs approved this year by the U.S. Food and Drug Administration for chronic conditions is $257,000, according to a new analysis from Reuters. Additionally, seven other recently launched drugs are priced at more than $200,000 per year. By comparison, the median annual price for the first 30 drugs marketed through mid-July 2021 was $180,000, according to a Journal of the American Medical Association study.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
